489OOsimertinib vs standard of care (SoC) EGFR-TKI as...

Annals of Oncology 2018 / 11 Vol. 29; Iss. suppl_9

489OOsimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes

Planchard, D, Boyer, M, Lee, J-S, Dechaphunkul, A, Cheema, P, Takahashi, T, Todd, A, McKeown, A, Rukazenkov, Y, Ohe, Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy425
Date:
November, 2018
File:
PDF, 104 KB
english, 2018
Conversion to is in progress
Conversion to is failed